Literature DB >> 21057723

[Ventilation-perfusion-lungscintigraphy using PET and 68Ga-labeled radiopharmaceuticals].

J Kotzerke1, M Andreeff, G Wunderlich, P Wiggermann, K Zöphel.   

Abstract

AIM: Imaging of lung perfusion with positron emission tomography (PET) is already possible with 68Ga labeled denaturized albumin. The purpose of our study was to produce and test a 68Ga labeled aerosol (Galligas®) for ventilation and 68Ga labeled albumin particles (microspheres) for perfusion imaging with PET. PATIENTS,
METHODS: Galligas was produced by simmering and burning generator eluted 68Ga solution (100 MBq/0.1 ml) in an ordinary technegas generator. Fifteen patients with suspicion on pulmonary embolism underwent PET/CT (Biograph 16) after inhalation of Galligas and application of 68Ga labeled microspheres. A low dose CT was acquired for attenuation correction (AC). Images were reconstructed with and without AC. The inhaled activity was calculated compared to the activity injected.
RESULTS: Inhaled radioaerosol Galligas demonstrated typical distribution as known from 99mTc-labeled technegas with homogeneous distribution in lung without hilar deposits. Attenuation corrected images resulted in artefacts in the lung base. Therefore, non-corrected images were used for making the results. Three out of fifteen patients showed a deficient perfusion whereas ventilation was normal corresponding to pulmonary embolism.
CONCLUSION: Lung scintigraphy with PET is feasible. Galligas is simple to produce (analogously to technegas). 68Ga labeled microspheres are available. The method is applicable to daily routine and rendered clinically relevant informations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21057723     DOI: 10.3413/nukmed-0348-10-09

Source DB:  PubMed          Journal:  Nuklearmedizin        ISSN: 0029-5566            Impact factor:   1.379


  6 in total

Review 1.  Is there still a role for SPECT-CT in oncology in the PET-CT era?

Authors:  Rodney J Hicks; Michael S Hofman
Journal:  Nat Rev Clin Oncol       Date:  2012-11-13       Impact factor: 66.675

2.  Effects of Positive End-Expiratory Pressure and Spontaneous Breathing Activity on Regional Lung Inflammation in Experimental Acute Respiratory Distress Syndrome.

Authors:  Thomas Kiss; Thomas Bluth; Anja Braune; Robert Huhle; Axel Denz; Moritz Herzog; Johannes Herold; Luigi Vivona; Marco Millone; Alice Bergamaschi; Michael Andreeff; Martin Scharffenberg; Jakob Wittenstein; Marcos F Vidal Melo; Thea Koch; Patricia R M Rocco; Paolo Pelosi; Jörg Kotzerke; Marcelo Gama de Abreu
Journal:  Crit Care Med       Date:  2019-04       Impact factor: 7.598

Review 3.  Radiopharmaceutical Labelling for Lung Ventilation/Perfusion PET/CT Imaging: A Review of Production and Optimization Processes for Clinical Use.

Authors:  Frédérique Blanc-Béguin; Simon Hennebicq; Philippe Robin; Raphaël Tripier; Pierre-Yves Salaün; Pierre-Yves Le Roux
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-22

4.  High-resolution imaging of pulmonary ventilation and perfusion with 68Ga-VQ respiratory gated (4-D) PET/CT.

Authors:  Jason Callahan; Michael S Hofman; Shankar Siva; Tomas Kron; Michal E Schneider; David Binns; Peter Eu; Rodney J Hicks
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-11-06       Impact factor: 9.236

5.  Comparative Effects of Volutrauma and Atelectrauma on Lung Inflammation in Experimental Acute Respiratory Distress Syndrome.

Authors:  Andreas Güldner; Anja Braune; Lorenzo Ball; Pedro L Silva; Cynthia Samary; Angelo Insorsi; Robert Huhle; Ines Rentzsch; Claudia Becker; Liane Oehme; Michael Andreeff; Marcos F Vidal Melo; Tilo Winkler; Paolo Pelosi; Patricia R M Rocco; Jörg Kotzerke; Marcelo Gama de Abreu
Journal:  Crit Care Med       Date:  2016-09       Impact factor: 7.598

6.  Effects of variable versus nonvariable controlled mechanical ventilation on pulmonary inflammation in experimental acute respiratory distress syndrome in pigs.

Authors:  Jakob Wittenstein; Martin Scharffenberg; Anja Braune; Robert Huhle; Thomas Bluth; Moritz Herzog; Andreas Güldner; Lorenzo Ball; Francesca Simonassi; Ines Zeidler-Rentzsch; Marcos F Vidal Melo; Thea Koch; Patricia R M Rocco; Paolo Pelosi; Jörg Kotzerke; Marcelo Gama de Abreu; Thomas Kiss
Journal:  Br J Anaesth       Date:  2020-02-04       Impact factor: 9.166

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.